ALAMEDA, Calif., March 21, 2018 /PRNewswire/ — Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singulex cTnI assay and Single Molecule Counting technology can independently predict moderate and severe coronary disease (CAD), suggesting its clinical utility for accurate, safe and cost-effective evaluation of patients in an outpatient setting, […]
Other News
BioCardia, Inc. Reports Fourth Quarter 2017 Financial Results and Business Highlights
SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, announced it filed its annual 10-K for the year ended December 31, 2017 with the Securities and Exchange Commission on Friday, March 16, 2018. BioCardia reported a net loss of $12.3 million […]
Micell Technologies Announces Expanded Patent Estate
DURHAM, N.C., March 20, 2018 /PRNewswire/ — Micell® Technologies, Inc., a privately-held, development-stage biomedical company, today provided an update on its recently expanded intellectual property portfolio. With the granting of 24 patents in 2017, including eight that issued in the fourth quarter, Micell’s extensive intellectual property portfolio comprises 186 patents (166 issued […]
BIOSENSE WEBSTER, INC. ANNOUNCES FIRST PATIENT TREATED IN STUDY OF MULTI-ELECTRODE RADIOFREQUENCY BALLOON CATHETER
Multicenter Study to Evaluate Balloon Ablation Catheter for Safety and Effectiveness in Achieving Pulmonary Vein Isolation in Treatment of Paroxysmal Atrial Fibrillation IRVINE, CA, MARCH 15 – Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, […]
Abbott’s MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation
ABBOTT PARK, Ill., March 19, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced that the Ministry of Health Labour and Welfare (MHLW) in Japan granted national reimbursement for the company’s MitraClip therapy to treat people with mitral regurgitation, a serious, progressive heart disease in which the mitral valve does not close properly, […]
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center draws cardiac experts from across the globe for EPLive 2018
AUSTIN, Texas, March 19, 2018 /PRNewswire/ — On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center hosted its fourth international symposium on complex arrhythmias, EPLive 2018. Nearly 200 leaders in the field of electrophysiology (EP) from Europe, Asia and Latin America, as […]
Society of Interventional Radiology bestows highest honors
LOS ANGELES, March 18, 2018 /PRNewswire-USNewswire/ — The Society Of Interventional Radiology (SIR) presented its highest honor, the SIR Gold Medal, to Karim Valji, M.D., FSIR; John A. Kaufman, M.D., M.S., FSIR; and Renate L. Soulen, M.D., FSIR, during its Annual Scientific Meeting in Los Angeles. These awards acknowledge distinguished and extraordinary service to SIR or to […]
Canon Medical Systems’ Aquilion ONE / GENESIS Edition Delivers Full Suite of Acute Stroke Solutions
TUSTIN, Calif.–(BUSINESS WIRE)– The Aquilion ONE™ / GENESIS Edition, capable of imaging the entire brain with a single 640-slice* rotation, covering 16 cm, gives clinicians the potential to diagnose and evaluate acute stroke quickly. The system can also capture both anatomy and function, which provides physicians with additional tools to […]
Endologix Reports Positive Results from Global ENCORE Analysis with Polymer Endovascular Aneurysm Repair (EVAR) Using Ovation Abdominal Stent Graft Systems
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced the first results from ENCORE, a pooled, global analysis of several prospective clinical trials and registries studying polymer endovascular aneurysm repair (Polymer EVAR) using Ovation® Abdominal Stent Graft Systems. ENCORE is a pooled, […]
Surefire Medical Presents Registry Data for Treatment of Liver Cancer at the 2018 SIR Annual Meeting
LOS ANGELES–(BUSINESS WIRE)–Surefire Medical, Inc. (Surefire), an oncology drug delivery company, announced today the presentation of data analyzing the efficacy and safety from its national patient registry. The data were presented as part of the 2018 Society for Interventional Radiology (SIR) Annual Meeting in Los Angeles, CA from March 17-22, 2018. […]



